Andrew J. Hull represents clients on matters related to administrative, civil, and criminal investigations and proceedings conducted by the DOJ, DEA, FDA, and state authorities under the federal Controlled Substances Act (CSA), the Federal Food, Drug, and Cosmetic Act, and related state laws and regulations. He also advises clients on compliance with federal and state laws and regulations related to the manufacturing, distributing, and dispensing of controlled substances and prescription drugs, particularly under the federal CSA and the Drug Supply Chain Security Act.
Prior to joining the firm, Mr. Hull served as the law clerk to the DEA’s Chief Administrative Law Judge (ALJ), John J. Mulrooney, II, a position he was awarded through the DOJ’s Attorney General’s Honors Program. As a law clerk, he co-authored with Judge Mulrooney the first in-depth primer for practitioners and pharmacies involved in administrative proceedings and hearings before the DEA, titled Drug Diversion Administrative Revocation and Application Hearings for Medical and Pharmacy Practitioners: A Primer for Navigating Murky, Drug-Infested Waters.
At law school, Mr. Hull served as the editor-in-chief of his school’s law review, and he is the author of numerous publications.